At 7.4% CAGR, the Europe Bromelain Market is Projected to be Worth US$ 20.79 million by 2030, Says Business Market Insights

According to Business Market Insights research, the Europe bromelain market was valued at US$ 11.72 million in 2022 and is expected to reach US$ 20.79 million by 2030, registering a CAGR of 7.4% from 2022 to 2030. Rising preference for natural plant-based ingredients and increasing applications in pharmaceutical & nutraceutical industry are among the critical factor attributed to the Europe bromelain market expansion.

Consumers are increasingly seeking products with natural additives and clean-label ingredients. Bromelain, a natural enzyme derived from the pineapple plant, is preferred as a natural additive over synthetic additives in various industries. Consumers are inclined toward consuming safer products that help them maintain overall health. The growing interest in chemical-free products boosts the demand for natural additives such as bromelain in industries such as pharmaceutical and nutraceuticals, food & beverages, and cosmetics. Bromelain is a plant protease preferred by consumers over animal proteases, as they carry a lower risk of disease transmission. Moreover, environmental concerns; sustainability; lower prices; and animal welfare, religious, and ethical issues are among other parameters driving the popularity of bromelain. In some countries, the use of enzymes synthesized from recombinant technology is prohibited in the food industry. In several countries, animal proteases or microbial fermentation are subject to religious issues (such as Halal compliance), which can be avoided by using plant-based components. Thus, the rising preference for natural, plant-based ingredients is expected to create lucrative growth opportunities in the Europe bromelain market during the forecast period.

On the contrary, high production cost hamper the growth Europe bromelain market .

Based on source, the Europe bromelain market is segmented into stem and fruit. The stem market segment held 75.8% share of the Europe bromelain market in 2022, amassing US$ 8.88 million. It is projected to garner US$ 15.61 million by 2030 to expand at 7.3% CAGR during 2022-2030.

By end user, the Europe bromelain market is categorized into food & beverages, pharmaceuticals & nutraceuticals, personal care, and others. The pharmaceuticals & nutraceuticals segment held 41.8% share of Europe bromelain market in 2022, amassing US$ 4.89 million. It is projected to garner US$ 8.33 million by 2030 to expand at 6.9% CAGR during 2022-2030.

Based on country, the Europe bromelain market is categorized into Germany, France, Italy, the UK, Russia, and the Rest of the Europe. The Rest of the Europe held 41.2% share of Europe bromelain market in 2022, amassing US$ 4.83 million. It is projected to garner US$ 8.54 million by 2030 to expand at 7.4% CAGR during 2022-2030.

Key players operating in the Europe bromelain market are Challenge Bioproducts Co Ltd, Creative Enzymes, Enzybel International SA, and Medikonda Nutrients, among others.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com